Rabies Vaccine for Prophylaxis and Treatment of Rabies: A Narrative Review. [PDF]
Kaye AD +11 more
europepmc +1 more source
Safety and immunogenicity of an inactivated vero cell-based rabies vaccine (Rabivax-S) in pre-exposure prophylaxis schedule in Vietnam. [PDF]
Hung PN +6 more
europepmc +1 more source
Cutaneous Small Vessel Vasculitis Following Anti-Rabies Vaccine. [PDF]
Agrawal I, Relhan V, Sahoo B, Guglani A.
europepmc +1 more source
Influencing factors and prediction of neutralizing antibodies in post-exposure rabies vaccine recipients. [PDF]
Huang C +6 more
europepmc +1 more source
Safety and efficacy assessment of an mRNA rabies vaccine in dogs, rodents, and cynomolgus macaques. [PDF]
Li J +8 more
europepmc +1 more source
Evaluation of the Efficacy of the Vaccine Production Process in Removing Residual Host Cell DNA from the Vero Cell Rabies Vaccine. [PDF]
Li J +11 more
europepmc +1 more source
Assessing anti-rabies vaccine response in humans: A rapid and high-throughput adaptable, pseudovirus-based neutralization assay as an alternative to rapid fluorescent focus inhibition test (RFFIT). [PDF]
Lupitha SS +6 more
europepmc +1 more source
Potency, immunogenicity, and efficacy of rabies vaccine: In vitro and in vivo approach. [PDF]
Akter F, Shamimuzzaman M.
europepmc +1 more source
Study on immune persistence of the CTN-1V strain rabies vaccine in humans. [PDF]
Wang L +10 more
europepmc +1 more source
Immunogenicity Persistence of Different Immunization Regimens of Rabies Vaccine in the 10-60 Years Age Group: A Follow-Up Report Based on Phase III Clinical Trial. [PDF]
Wang Y +8 more
europepmc +1 more source

